About Stability Biologics
Stability Biologics is a company based in Nashville (United States) founded in 2010 was acquired by MiMedx Group in January 2016. Stability Biologics offers products and services including AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips. Stability Biologics operates in a competitive market with competitors including GSK, Avidity Biosciences, Humacyte, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Nashville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stability Biologics, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
MiMedx Group
(Jan 10, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stability Biologics
Stability Biologics offers a comprehensive portfolio of products and services, including AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips.
Advanced allograft for regenerative medicine and tissue repair applications.
Specialized allograft for surgical wound healing and patient care.
Allograft designed for burn treatment and skin regeneration processes.
Material for bone grafting in medical and regenerative procedures.
Chips used for bone repair and structural support in surgeries.
Funding Insights of Stability Biologics
Detailed funding history for Stability Biologics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Stability Biologics
Stability Biologics has secured backing from 1 investor. Prominent investors backing the company include MiMedx Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
Locked | Locked | Locked |
Investor details for Stability Biologics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stability Biologics
Investment portfolio details for Stability Biologics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stability Biologics
Detailed financials for Stability Biologics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stability Biologics Comparisons
Peer comparison for Stability Biologics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stability Biologics
Stability Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Humacyte, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Human tissue-based products are developed for vascular disease applications.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
Detailed competitors of Stability Biologics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stability Biologics
Complete news archive for Stability Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stability Biologics
Stability Biologics was founded in 2010.
Stability Biologics is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Founded in 2010 in Nashville, United States, Stability Biologics operates in the tissue engineering sector. Bone tissue and demineralized bone matrix are manufactured for grafting procedures, alongside split-thickness skin grafts for burn treatment and traditional allograft cancellous bone products. Operations began as an FDA-registered tissue bank, with a merger to MiMedx occurring in 2016 to expand biomaterials capabilities.
Stability Biologics's top competitors include Sutro Biopharma, Synthego and Humacyte.
Stability Biologics offers AmnioCore, AmnioCore Surgical, AmnioCore Burn, Cortical Fibers, and Cancellous Chips.
Stability Biologics has 1 investor. Key investors include MiMedx Group.